TI Podcast Letter 80 - Dabigatran for atrial fibrillation: Why we can not rely on RE-LY

Submitted by Therapeutics Initiative on Tue, 2011-11-29 17:23
Printer VersionPrinter Version

 

THERAPEUTICS LETTER ISSUE 80 / JAN - MAR 2011

Listen to Alan Cassels interview Dr Aaron Tejani from the Therapeutics Initiative at UBC and Fraser Health regarding the use of dabigatran for atrial fibrilation.

Read Therapeutics Letter 80